참고문헌 (30)

1. [1] Roffi M Patrono C Collet J-P 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC) . Eur Heart J 2016 ; 37 : 267 – 315 . 26320110 

2. [2] Levine GN Bates ER Bittl JA 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines . J Thorac Cardiovasc Surg 2016 ; 152 : 1243 – 75 . 27751237 

3. [3] Antman EM Wiviott SD Murphy SA Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON–TIMI 38 (TRial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel–thrombolysis in myocardial infarction) analysis . J Am Coll Cardiol 2008 ; 51 : 2028 – 33 . 18498956 

4. [4] Becker RC Bassand JP Budaj A Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the platelet inhibition and patient outcomes (PLATO) trial . Eur Heart J 2011 ; 32 : 2933 – 44 . 22090660 

   상세보기

5. [5] Lee JH Ahn SG Park B A pharmacodynamic study of the optimal P2Y12 inhibitor regimen for East Asian patients with acute coronary syndrome . Korean J Intern Med 2015 ; 30 : 620 – 8 . 26354056 

   상세보기

6. [6] Goto S Huang C-H Park S-J Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome–randomized, double-blind, phase III PHILO study . Circ J 2015 ; 79 : 2452 – 60 . 26376600 

   상세보기

7. [7] Park K-H Jeong MH Kim HK Comparison of prasugrel versus clopidogrel in Korean patients with acute myocardial infarction undergoing successful revascularization . J Cardiol 2018 ; 71 : 36 – 43 . 28673508 

   상세보기

8. [8] Park K-H Jeong MH Ahn Y Comparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization; from Korea Acute Myocardial Infarction Registry—National Institute of Health . Int J Cardiol 2016 ; 215 : 193 – 200 . 27128530 

9. [9] Valgimigli M Bueno H Byrne RA 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS . Eur J Cardio-Thorac Surg 2017 ; 53 : 34 – 78 . 

10. [10] Austin PC An introduction to propensity score methods for reducing the effects of confounding in observational studies . Multivariate Behav Res 2011 ; 46 : 399 – 424 . 21818162 

    상세보기

11. [11] Jung JH Tantry US Gurbel PA Current antiplatelet treatment strategy in patients with diabetes mellitus . Diabetes Metab J 2015 ; 39 : 95 – 113 . 25922803 

    상세보기

12. [12] Sarwar N Gao P Seshasai SR Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies . Lancet (London, England) 2010 ; 375 : 2215 – 22 . 

13. [13] Ferreiro JL Angiolillo DJ Diabetes and antiplatelet therapy in acute coronary syndrome . Circulation 2011 ; 123 : 798 – 813 . 21343595 

    상세보기

14. [14] Angiolillo DJ Bernardo E Sabate M Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease . J Am Coll Cardiol 2007 ; 50 : 1541 – 7 . 17936152 

    상세보기

15. [15] Mangiacapra F Peace A Barbato E Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitus . Platelets 2014 ; 25 : 348 – 56 . 23971913 

    상세보기

16. [16] Tantry US Bonello L Aradi D Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding . J Am Coll Cardiol 2013 ; 62 : 2261 – 73 . 24076493 

    상세보기

17. [17] Wiviott SD Braunwald E McCabe CH Prasugrel versus clopidogrel in patients with acute coronary syndromes . N Engl J Med 2007 ; 357 : 2001 – 15 . 17982182 

    상세보기

18. [18] Roe MT Armstrong PW Fox KA Prasugrel versus clopidogrel for acute coronary syndromes without revascularization . N Engl J Med 2012 ; 367 : 1297 – 309 . 22920930 

    상세보기

19. [19] Wiviott SD Braunwald E Angiolillo DJ Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel–thrombolysis in myocardial infarction 38 . Circulation 2008 ; 118 : 1626 – 36 . 18757948 

20. [20] Wiviott SD Desai N Murphy SA Efficacy and safety of intensive antiplatelet therapy with prasugrel from TRITON-TIMI 38 in a core clinical cohort defined by worldwide regulatory agencies . Am J Cardiol 2011 ; 108 : 905 – 11 . 21816379 

    상세보기

21. [21] James S Angiolillo DJ Cornel JH Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the platelet inhibition and patient outcomes (PLATO) trial . Eur Heart J 2010 ; 31 : 3006 – 16 . 20802246 

    상세보기

22. [22] Hayden MR Tyagi SC Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation . Cardiovasc Diabetol 2004 ; 3 : 1 . 14761253 

    상세보기

23. [23] Jeong Y-H East asian paradox”: challenge for the current antiplatelet strategy of “one-guideline-fits-all races” in acute coronary syndrome . Curr Cardiol Rep 2014 ; 16 : 485 . 24668607 

    상세보기

24. [24] Shen AY-J Yao JF Brar SS Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation . J Am Coll Cardiol 2007 ; 50 : 309 – 15 . 17659197 

    상세보기

25. [25] Ma C Current antithrombotic treatment in East Asia: some perspectives on anticoagulation and antiplatelet therapy . Thromb haemostasis 2012 ; 108 : 1014 – 8 . 

26. [26] Levine GN Jeong Y-H Goto S World heart federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI . Global Heart 2014 ; 9 : 457 – 67 . 25592800 

    상세보기

27. [27] Saito S Isshiki T Kimura T Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome . Circ J 2014 ; 78 : 1684 – 92 . 24759796 

28. [28] Angiolillo DJ Bernardo E Ramírez C Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment . J Am Coll Cardiol 2006 ; 48 : 298 – 304 . 16843179 

    상세보기

29. [29] Sim DS Jeong MH Kang JC Current management of acute myocardial infarction: experience from the Korea Acute Myocardial Infarction Registry . J Cardiol 2010 ; 56 : 1 – 7 . 20554156 

    상세보기

30. [30] Wallentin L Becker RC Budaj A Ticagrelor versus clopidogrel in patients with acute coronary syndromes . New Engl J Med 2009 ; 361 : 1045 – 57 . 19717846